
Keywords: BM-MNC, bone marrow-derived mononuclear cell; BM-MSC, bone marrow-derived mesenchymal stem cell; ECM, extracellular matrix; EPC, endothelial progenitor cells; FDA, Food and Drug Administration; iPS, inducible pluripotent stem cell; MSC, mesenchymal stem c